Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
mercredi, octobre 21
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Cencora Inc
COR
NYSE
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$343.27
3.27
0.96%
Dern. MÀJ: Oct 21, 8:17 AM
$339.25
-0.75
-0.22%
Get Report
Aperçu
Actualités
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Dividendes
Comparer
Options
Rapport sur les stocks
Privacy Manager
PRO
Pourquoi cela bouge-t-il ?:
Cencora shares are trading lower after the company announced it will acquir...
Résultats:
Résultats Q4 2026 dans dans 14 jours à partir de maintenant le mer. nov. 4th, avant l'ouverture du marché
Fusions et acquisitions:
American Oncology Network (AONC) announced today it will be acquired by Cencora (COR) for $2.4B
Cencora Financials
Cencora (COR) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Cencora Says Certain Walgreens Volume Moves Outside Cencora From July 1, 2026; Reaffirms FY26 Adj Diluted EPS Guidance Range Of $17.75-$17.95; Says Prime Vendor Agreement With Walgreens Remains Unchanged
Beginning July 1, 2026, certain Walgreens volume that was being serviced by Cencora, Inc. (the "Company" or "Cencora") separate from the prime vendor agreement began moving outside the Company. The prime
Benzinga Newsdesk
Cencora Sees Specialty Growth Continue While GLP-1 Mix Weighs on Margins
Cencora beats third-quarter earnings and revenue estimates, raised fiscal 2026 EPS guidance and maintains its annual sales forecast.
Vandana Singh
PRO
Cencora Raises FY2026 Adj EPS Guidance from $17.70-$17.90 to $17.75-$17.95 vs $17.79 Est; Affirms FY2026 Sales Guidance of $334.152B-$340.578B vs $337.203B Est
Cencora (NYSE:COR) raises FY2026 Adj EPS guidance from $17.70-$17.90 to $17.75-$17.95 vs $17.79 analyst estimate. Affirms FY2026 sales outlook from $334.152 billion-$340.578 billion to $334.152 billion-$340.578 billion
Benzinga Newsdesk
PRO
Cencora Q3 Adj. EPS $4.48 Beats $4.35 Estimate, Sales $84.754B Beat $84.315B Estimate
Cencora (NYSE:COR) reported quarterly earnings of $4.48 per share which beat the analyst consensus estimate of $4.35 by 2.99 percent. This is a 12 percent increase over earnings of $4.00 per share from the same period
Benzinga Newsdesk
Earnings Scheduled For May 6, 2026
Benzinga Insights
Why Is Cencora Stock Trading Lower On Wednesday?
Cencora stock falls after Q2 earnings miss and lower sales guidance, despite raising EPS outlook and reporting mixed segment growth.
Vandana Singh
